Vanderbilt University Medical Center and Brigham and Women’s Hospital in Boston recently collaborated on a study analysis to determine the effect of a tailored, pharmacist-delivered health literacy intervention on unplanned hospital readmission or emergency department visit following discharge.

C. Michael Stein, MBChB., and his colleagues at Vanderbilt University Medical Center have received a five-year, $1.35 million award from the Arthritis Foundation to develop new biomarkers for rheumatoid arthritis that also may revolutionize treatment.

Investigators at Vanderbilt University Medical Center have published research regarding an important feature of colorectal cancer (CRC) that could eventually lead to the development of non-invasive means of monitoring cancer progression. After lung cancer, CRC is the second-most lethal cancer in the United States.

When Rob Hood, M.D., began practicing cardiology 30 years ago he could not have imagined that fitness would one day be measured on a device worn around his wrist.

A protein that suppresses a key cancer pathway in the colon may be a potential biomarker for colitis-associated tumors, researchers at Vanderbilt University Medical Center reported last month in the journal Gut.

Vanderbilt investigators have discovered a way to overcome the resistance of some lung cancers to certain targeted therapies, which could lead to more effective treatments for lung cancer patients.

The Houston Academy of Medicine and Harris County Medical Society awarded William Schaffner, M.D., professor of Preventive Medicine, with the 2016 John P. McGovern Compleat Physician Award last week.